Literature DB >> 1719467

Nuclear localization is essential for the activity of p53 protein.

G Shaulsky1, N Goldfinger, M S Tosky, A J Levine, V Rotter.   

Abstract

p53 appears to be a growth regulator, the perturbation of which induces changes in normal cell proliferation. Wild-type p53 protein is thought to function as a growth arrest gene, whereas mutant p53, which accumulates in transformed cells, has been shown to enhance malignant transformation. Both wild-type and mutant p53 migrate into the cell nucleus by means of identical nuclear localization signals (NLS) inherent in their primary sequences. Results presented here show that the suppressive activity of wild-type p53 measured as the reduction of transformation of primary rat fibroblasts induced by co-transfection with ras and either E1A or mutant p53, as well as the transformation enhancement of mutant p53 estimated by cooperation with ras in transformation of primary rat fibroblasts, is dependent upon nuclear localization signals in p53 protein. While transfection of unmodified wild-type p53 significantly reduces the number of rat embryonic fibroblast-transformed foci induced by E1A and ras or mutant p53 and ras, the wild-type p53 protein without NLS has completely lost this suppressive activity. Partially defective NLS wild-type p53, with a reduced nuclear accumulation ability, still exhibits some suppressive activity. In addition, we found that plasmids coding for intact mutant p53 protein efficiently cooperate with the ras oncogene, whereas the corresponding plasmids without NLS are totally inert. On this basis we conclude that nuclear localization of both wild-type and mutant p53 is a fundamental feature for manifesting the activities of these proteins. Both the suppressor activity mediated by the wild-type p53 and enhancement of transformation mediated by the mutant p53 require nuclear localization of the proteins to function.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1719467

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  47 in total

1.  Stress signals utilize multiple pathways to stabilize p53.

Authors:  M Ashcroft; Y Taya; K H Vousden
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Circadian variation in the expression of cell-cycle proteins in human oral epithelium.

Authors:  G A Bjarnason; R C Jordan; R B Sothern
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

3.  Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding.

Authors:  E Shaulian; A Zauberman; D Ginsberg; M Oren
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

4.  Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells.

Authors:  A Kovacs; M L Weber; L J Burns; H S Jacob; G M Vercellotti
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 5.  Nuclear localization signals overlap DNA- or RNA-binding domains in nucleic acid-binding proteins.

Authors:  E C LaCasse; Y A Lefebvre
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

6.  p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells.

Authors:  O Eizenberg; A Faber-Elman; E Gottlieb; M Oren; V Rotter; M Schwartz
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

7.  Distinct residues of human p53 implicated in binding to DNA, simian virus 40 large T antigen, 53BP1, and 53BP2.

Authors:  S K Thukral; G C Blain; K K Chang; S Fields
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  NS1- and minute virus of mice-induced cell cycle arrest: involvement of p53 and p21(cip1).

Authors:  A Op De Beeck; J Sobczak-Thepot; H Sirma; F Bourgain; C Brechot; P Caillet-Fauquet
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors.

Authors:  U M Moll; M LaQuaglia; J Bénard; G Riou
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion.

Authors:  U M Moll; G Riou; A J Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.